Regulation of laminar flow atheroprotective genes by HDAC5

HDAC5 对层流动脉粥样硬化保护基因的调节

基本信息

  • 批准号:
    8370488
  • 负责人:
  • 金额:
    $ 38.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-16 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis is the major cause of death and disability in the United States. Endothelial dysfunction and inflammation are hallmarks of atherosclerosis. The risk factors such as hypertension, obesity, diabetes, smoking, hyperlipidemia, and genetic predisposition create a proinflammatory environment that leads to endothelial dysfunction and atherogenesis. The lesions of atherosclerosis have a non-uniform distribution in the human vasculature. Straight regions of arteries are exposed to steady laminar blood flow and are protected from atherosclerosis, whereas regions containing bifurcations and curvatures are characterized by disturbed blood flow that predisposes vessels to atherosclerotic lesion formation. The overall goals of this project are to elucidate the nature of laminar flow atheroprotection, identify the key molecules and signal pathways in the anti-atherogenic programs of physiological laminar flow. We will further define new strategies to activate the atheroprotective mechanism in the atheroprone regions of arteries exposed to disturbed flow to prevent atherosclerosis. The transcription factor Kr?ppel-like factor 2 (KLF2) has emerged as a key atheroprotective gene integrating multiple endothelial functions. In particular, KLF2 is a laminar flow responsive gene and mediates many atheroprotective effects of laminar flow including the inhibition of leukocyte adhesion to endothelium and the improvement of endothelial dysfunction through enhancing endothelial nitric oxide synthase (eNOS) expression and activity. However, the molecular mechanisms connecting laminar flow to KLF2 activation and physiological function in endothelial biology remain largely elusive. New evidence emerging from our laboratory suggests that histone deacetylase 5 (HDAC5) is a crucial molecular linker facilitating L-flow activation of KLF2 in the atheroprotective processes. To test our hypothesis, we will use a combination of biochemical, cell biological and genetic approaches in cultured cells and mice to examine the functional role of HDAC5 and molecular mechanisms in laminar flow regulation of KLF2 and atheroprotection. The results of this project will provide a detailed understanding of the mechanisms involved in laminar flow atheroprotection and will have implications for the development of new therapeutic approaches, such as specifically removing HDAC5 repression on KLF2, to limit atherosclerosis. PUBLIC HEALTH RELEVANCE: Atherosclerosis is the major cause of death and disability in the United States. The lesions of atherosclerosis show a focal pattern of distribution in the human vasculature, and steady laminar blood flow within large straight arteries provides an atheroprotective function mainly through upregulation of the atheroprotective genes in endothelial cells. We have recently found that HDAC5, an important transcriptional repressor, is involved in laminar flow-mediated regulation of the atheroprotective genes. This proposed study will investigate mechanical and molecular mechanisms derived from laminar flow on HDAC5, and develop novel approaches to inhibit HDAC5, establishing exogenous atheroprotection in traditionally artheroprone vasculature. The proposal will significantly increase our understanding of mechanisms by which laminar flow mediates atheroprotection, and therefore provide the basis to develop new therapies to prevent atherosclerosis.
描述(申请人提供):动脉粥样硬化是美国人死亡和残疾的主要原因。内皮功能障碍和炎症是动脉粥样硬化的特征。高血压、肥胖、糖尿病、吸烟、高脂血症和遗传易感性等危险因素会造成促炎环境,从而导致内皮功能障碍和动脉粥样硬化。动脉粥样硬化的病变在人体血管中的分布不均匀。动脉的直段暴露在稳定的层流血流中,并受到动脉粥样硬化的保护,而包含分叉和弯曲的区域的特点是血流紊乱,容易导致动脉粥样硬化病变的形成。本项目的总体目标是阐明层流动脉粥样硬化保护的本质,确定生理性层流抗动脉粥样硬化过程中的关键分子和信号通路。我们将进一步定义新的策略,以激活暴露在扰动血流中的动脉粥样硬化区域的动脉粥样硬化保护机制,以防止动脉粥样硬化。转录因子Kr?ppel-like factor2(KLF2)是一种整合多种内皮功能的重要动脉粥样硬化保护基因。尤其是,KLF2是一种层流反应基因,通过增强内皮型一氧化氮合酶(ENOS)的表达和活性,介导了层流的许多动脉粥样硬化保护作用,包括抑制白细胞与内皮的黏附,改善内皮功能障碍。然而,在内皮生物学中,层流与KLF2激活和生理功能之间的分子机制仍然很难理解。本实验室的新证据表明,组蛋白脱乙酰基酶5(HDAC5)是在动脉粥样硬化保护过程中促进KLF2 L流动激活的重要分子连接物。为了验证我们的假设,我们将在培养细胞和小鼠中结合生化、细胞生物学和遗传学方法来研究HDAC5在KLF2层流调节和动脉粥样硬化保护中的功能作用和分子机制。该项目的结果将提供对层流动脉粥样硬化保护机制的详细了解,并将对开发新的治疗方法具有指导意义,例如特别取消对KLF2的HDAC5抑制,以限制动脉粥样硬化。 公共卫生相关性:在美国,动脉粥样硬化是导致死亡和残疾的主要原因。动脉粥样硬化的病变在人体血管系统中呈局灶性分布,大直动脉内稳定的层流血流主要通过上调内皮细胞中的动脉粥样硬化保护基因来提供动脉粥样硬化保护功能。我们最近发现,作为一种重要的转录抑制因子,HDAC5参与了层流介导的动脉粥样硬化保护基因的调节。这项拟议的研究将研究HDAC5上层流产生的力学和分子机制,并开发新的方法来抑制HDAC5,在传统的动脉粥样硬化血管系统中建立外源性动脉粥样硬化保护。这一建议将大大提高我们对层流介导动脉粥样硬化保护机制的理解,从而为开发预防动脉粥样硬化的新疗法提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZHENG-GEN JIN其他文献

ZHENG-GEN JIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZHENG-GEN JIN', 18)}}的其他基金

Epigenetic regulation of vascular endothelial genes and laminar flow atheroprotection
血管内皮基因的表观遗传调控和层流动脉粥样硬化保护
  • 批准号:
    10254223
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Epigenetic regulation of vascular endothelial genes and laminar flow atheroprotection
血管内皮基因的表观遗传调控和层流动脉粥样硬化保护
  • 批准号:
    10430272
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
SIRT6 and Alzheimer Disease
SIRT6 和阿尔茨海默病
  • 批准号:
    10121354
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
SIRT6 and vascular endothelial homeostasis
SIRT6 与血管内皮稳态
  • 批准号:
    9900038
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
SIRT6 and vascular endothelial homeostasis
SIRT6 与血管内皮稳态
  • 批准号:
    10646350
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
SIRT6 and vascular endothelial homeostasis
SIRT6 与血管内皮稳态
  • 批准号:
    10529926
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
SIRT6 and vascular endothelial homeostasis
SIRT6 与血管内皮稳态
  • 批准号:
    9380604
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
Regulation of angiogenesis by transcription factors
转录因子对血管生成的调节
  • 批准号:
    9241422
  • 财政年份:
    2016
  • 资助金额:
    $ 38.38万
  • 项目类别:
Molecular regulation of angiogenesis
血管生成的分子调控
  • 批准号:
    8877622
  • 财政年份:
    2012
  • 资助金额:
    $ 38.38万
  • 项目类别:
Molecular regulation of angiogenesis
血管生成的分子调控
  • 批准号:
    8511811
  • 财政年份:
    2012
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似海外基金

Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
  • 批准号:
    22K08681
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
  • 批准号:
    474506
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Studentship Programs
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
  • 批准号:
    466496
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
  • 批准号:
    451838
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10230924
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10399593
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10570987
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
  • 批准号:
    19K05343
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
  • 批准号:
    18K08528
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
  • 批准号:
    18K15615
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了